Track topics on Twitter Track topics that are important to you
FORT WORTH, Texas, Aug. 11, 2015 (GLOBE NEWSWIRE) -- APPYEA, Inc. (OTCQB:APYP) – AppYea's development team is configuring the Company's current Universal Studio/Disney World wait time apps to be compatible with the Apple WatchOS 2, scheduled to launch this fall. AppYea's management plans an aggressive marketing campaign to coincide with Apple's launch. The Company currently offers 7 different Disney World/Universal Studio theme park wait time apps in 5 different languages on both the Apple App Store and Google Play.
Based on feedback from the Company's team of developers, the Apple WatchOS 1 which launched earlier this year is not 100% compatible with third party apps, causing long load times. According to CNET, who tracks all the latest consumer technology breakthroughs, the Apple WatchOS 2 will introduce a host of new features, including getting bits of at-a-glance info from third party apps on watch faces and updated software which will open up the door to much improved third party apps. Click here to read the full story: http://www.cnet.com/products/apple-watch/2/
On July 13, 2015, AppYea announced it had submitted offers for the acquisition of two mobile application portfolios to add to their growing holdings, and that additional information will be released when finalized.
About AppYea, Inc
AppYea Inc., founded in 2012, is a mobile application developer for iOS, Google Play, and Amazon platforms. The Company operates its own titles as well as provides strategic partnerships with promising mobile app developers. AppYea focuses on a number of different categories including next-generation social networks and gaming. The company is headquartered in Ft Worth, Texas. The Company's common stock trades on the OTCQB, under the ticker symbol "APYP." Find out more by visiting: http://appyea.com/about/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
CONTACT: Stuart T. Smith SmallCapVoice.com E-mail: firstname.lastname@example.org Website: www.smallcapvoice.comNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.